Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, reflecting the current epidemics of obesity, insulin resistance, type 2 diabetes mellitus, and metabolic syndrome. NAFLD is characterized by the accumulation of fat in the liver, and is known to be a cause of cirrho...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Ángela, García-Lozano, María Rosario, Gil-Gómez, Antonio, Romero-Gómez, Manuel, Ampuero, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039703/
https://www.ncbi.nlm.nih.gov/pubmed/35528989
http://dx.doi.org/10.14218/JCTH.2021.00247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039703/
https://www.ncbi.nlm.nih.gov/pubmed/35528989
http://dx.doi.org/10.14218/JCTH.2021.00247

Ejemplares similares